The total revenue for the quarter ended December 2022 remained nearly unchanged at Rs. 745.69 millions.A comparatively good net profit growth of 32.41% to Rs. 105.48 millions was reported for the quarter ended December 2022 compared to Rs. 79.66 millions of previous same quarter.OP of the company witnessed a marginal growth to 157.45 millions from 132.89 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 745.69 716.99 4.00 2601.44 2391.39 8.78 3135.11 2474.50 26.70
Other Income 74.59 60.28 23.74 153.88 165.27 -6.89 158.41 171.80 -7.79
PBIDT 157.45 132.89 18.48 501.39 473.07 5.99 566.35 363.29 55.89
Interest 1.06 1.04 1.92 3.43 3.62 -5.25 5.32 6.53 -18.53
PBDT 156.39 131.85 18.61 497.96 469.45 6.07 561.03 356.76 57.26
Depreciation 20.58 23.13 -11.02 62.49 64.17 -2.62 88.06 82.32 6.97
PBT 135.81 108.72 24.92 435.47 405.28 7.45 472.97 274.44 72.34
TAX 30.33 29.06 4.37 111.05 94.46 17.56 120.40 53.00 127.17
Deferred Tax 0.87 7.28 -88.05 -5.42 0.84 -745.24 -5.74 9.27 -161.92
PAT 105.48 79.66 32.41 324.42 310.82 4.38 352.57 221.44 59.22
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 21.11 18.53 13.92 19.27 19.78 -2.57 18.06 14.68 23.05

Albert David Share Price

1417.95 48.70 (3.56%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.